Plexus Corp (PLXS - Free Report) reported fiscal fourth-quarter 2017 adjusted earnings of 84 cents per share which beat the Zacks Consensus Estimate of 82 cents. However, revenues of $670 million fell way short of the consensus mark of $681 million.
On a year-over-year basis, earnings and revenues increased 2.4% and 2.6%, respectively.
Revenues from the Communications sector (21% of total revenue) grew 9.4% year over year to $140 million.
Healthcare/Life Sciences revenues (35%) were up 21.4% from the year-ago quarter to $233 million.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Plexus Corp (PLXS - Free Report) reported fiscal fourth-quarter 2017 adjusted earnings of 84 cents per share which beat the Zacks Consensus Estimate of 82 cents. However, revenues of $670 million fell way short of the consensus mark of $681 million.
On a year-over-year basis, earnings and revenues increased 2.4% and 2.6%, respectively.
Revenues from the Communications sector (21% of total revenue) grew 9.4% year over year to $140 million.
Healthcare/Life Sciences revenues (35%) were up 21.4% from the year-ago quarter to $233 million.
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PLXS - FREE
Get the latest research report on JBL - FREE
Get the latest research report on FLEX - FREE
Get the latest research report on CLS - FREE